← FDA DRUG APPROVALS

FDA ANDA · ANDA040733

DIPYRIDAMOLE

Sponsor: RISING

APPLICATION
ANDA040733
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-13
LATEST ACTION
2021-02-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DIPYRIDAMOLEPrescription
DIPYRIDAMOLE 75MG · TABLET · ORAL
DIPYRIDAMOLEPrescription
DIPYRIDAMOLE 25MG · TABLET · ORAL
DIPYRIDAMOLEPrescription
DIPYRIDAMOLE 50MG · TABLET · ORAL

Approval history

2021-02-02Labeling · Supplement 6 · standardAP
2016-11-30Manufacturing (CMC) · Supplement 4AP
2007-02-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →